Fannin Innovation Studio Accepted Into NIDA's Medications Di

Houston, TX (PRWEB) October 03, 2022 -- Fannin Innovation Studio, an early-stage biomedical development and commercialization company, announces that the

Related Keywords

Corey Hopkins , University Of Nebraska Medical Center , Department Of Pharmaceutical Sciences College Pharmacy , National Institutes Of Health , Addiction Treatment Discovery Program , Division Of Therapeutics , National Institute Of Drug Abuse , Innovation Studio , National Institute , Drug Abuse , National Institutes , Medical Consequences , Atul Varadhachary , Managing Partner , Professor Corey Hopkins , Pharmaceutical Sciences , Nebraska Medical Center , Managing Director , Dev Chatterjee , Fannin Innovation Studio , Fannin Founded Entities , Press Release ,